SAGE: Sage Therapeutics, Inc. Stock

by  •  • Comments Off on SAGE: Sage Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 778.38
Enterprise Value ($M) 707.39
Book Value ($M) 799.53
Book Value / Share 13.30
Price / Book 0.97
NCAV ($M) 786.60
NCAV / Share 13.09
Price / NCAV 0.99

Profitability (mra)
Return on Invested Capital (ROIC) -0.67
Return on Assets (ROA) -0.44
Return on Equity (ROE) -0.48

Liquidity (mrq)
Quick Ratio 10.49
Current Ratio 10.51

Balance Sheet (mrq) ($M)
Current Assets 869.35
Assets 882.28
Liabilities 82.75
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 86.45
Operating Income -546.46
Net Income -541.49
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -540.59
Cash from Investing 442.91
Cash from Financing 6.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Rtw Investments, Lp 8.70
02-13 13G/A Bb Biotech Ag 5.80 13.05
02-13 13G/A Vanguard Group Inc 8.86 8.88
02-09 13G/A Fmr Llc 9.13 -16.32
02-08 13G/A Wellington Management Group Llp 10.10 -4.74
01-26 13G/A BlackRock Inc. 7.80 -5.01
01-24 13G State Street Corp 6.53

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-25 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-02-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q l UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-24 337,646 1,984,657 17.01
2024-04-23 132,407 662,453 19.99
2024-04-22 96,762 637,402 15.18
2024-04-19 145,129 560,059 25.91

(click for more detail)

Similar Companies
RVNC – Revance Therapeutics, Inc. RWOD – Redwoods Acquisition Corp.
RYTM – Rhythm Pharmaceuticals, Inc. SCYX – SCYNEXIS, Inc.
SGMT – Sagimet Biosciences Inc.


Financial data and stock pages provided by
Fintel.io